Tag Archives: Committee of Experts on the COVID-19 Matter

Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …

Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …